| Literature DB >> 9523119 |
Abstract
The past year has born witness to compelling demonstrations of the utility of peptide complexes with glucose regulated protein 94 (GRP94, also known as gp96) in cancer immunotherapy. Insights into the structural basis of peptide binding to GRP94 have been obtained and the role of the transporter for antigen presentation in defining the GRP94-bound peptide composition has been determined.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9523119 DOI: 10.1016/s0952-7915(98)80039-3
Source DB: PubMed Journal: Curr Opin Immunol ISSN: 0952-7915 Impact factor: 7.486